SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-003570
Filing Date
2024-02-06
Accepted
2024-02-06 16:15:23
Documents
2
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1346
2 POWER OF ATTORNEY (PUBLIC): POA_LOVE doc1.txt EX-24 3057
  Complete submission text file 0001127602-24-003570.txt   5961
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
LOVE TED W (Reporting) CIK: 0001188919 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19731 | Film No.: 24600454